Your browser doesn't support javascript.
loading
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Vermeire, Severine; Lakatos, Peter L; Ritter, Timothy; Hanauer, Stephen; Bressler, Brian; Khanna, Reena; Isaacs, Kim; Shah, Saumin; Kadva, Alysha; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Eden, Christopher; Zhang, Wenhui; Feagan, Brian G.
Afiliación
  • Vermeire S; Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
  • Lakatos PL; McGill University Health Center, Montreal, QC, Canada.
  • Ritter T; GI Alliance, Southlake, TX, USA.
  • Hanauer S; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Bressler B; Gastrointestinal Research Institute, St Paul's Hospital, Vancouver, BC, Canada.
  • Khanna R; University of Western Ontario, London, ON, Canada.
  • Isaacs K; Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Shah S; Gujarat Hospital, Gastro and Vascular Centre, Nirmal Hospital, Surat, Gujarat, India.
  • Kadva A; Genentech, South San Francisco, CA, USA.
  • Tyrrell H; Roche, Welwyn Garden City, UK.
  • Oh YS; Genentech, South San Francisco, CA, USA.
  • Tole S; Genentech, South San Francisco, CA, USA.
  • Chai A; Genentech, South San Francisco, CA, USA.
  • Pulley J; Roche, Welwyn Garden City, UK.
  • Eden C; Genentech, South San Francisco, CA, USA.
  • Zhang W; Genentech, South San Francisco, CA, USA.
  • Feagan BG; Alimentiv, University of Western Ontario, London, ON, Canada. Electronic address: brian.feagan@robartsinc.com.
Lancet Gastroenterol Hepatol ; 7(1): 28-37, 2022 01.
Article en En | MEDLINE | ID: mdl-34798037
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Colitis Ulcerosa / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2022 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Colitis Ulcerosa / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2022 Tipo del documento: Article País de afiliación: Bélgica